Biology of Blood and Marrow Transplantation
Volume 13, Issue 10 , Pages 1233-1243 , October 2007

Similar Outcomes of Cryopreserved Allogeneic Peripheral Stem Cell Transplants (PBSCT) Compared to Fresh Allografts

  • Dong Hwan Kim

      Affiliations

    • Department of Hematology/Medical Oncology, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, Canada
    • Department of Hematology and Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
    • ,
  • Nazir Jamal

      Affiliations

    • Department of Hematology/Medical Oncology, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, Canada
    • ,
  • Ronnie Saragosa

      Affiliations

    • Department of Hematology/Medical Oncology, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, Canada
    • ,
  • David Loach

      Affiliations

    • Department of Hematology/Medical Oncology, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, Canada
    • ,
  • Janice Wright

      Affiliations

    • Department of Hematology/Medical Oncology, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, Canada
    • ,
  • Vikas Gupta

      Affiliations

    • Department of Hematology/Medical Oncology, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, Canada
    • ,
  • John Kuruvilla

      Affiliations

    • Department of Hematology/Medical Oncology, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, Canada
    • ,
  • Jeffrey H. Lipton

      Affiliations

    • Department of Hematology/Medical Oncology, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, Canada
    • ,
  • Mark Minden

      Affiliations

    • Department of Hematology/Medical Oncology, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, Canada
    • ,
  • Hans A. Messner

      Affiliations

    • Department of Hematology/Medical Oncology, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, Canada
    • Corresponding Author InformationCorrespondence and reprint requests: Hans A. Messner, MD/PhD, Department of Hematology/Medical Oncology, Princess Margaret Hospital, University Health Network, Toronto, ON, Canada, M5G 2M9.

Received 9 May 2007 ,Accepted 5 July 2007.

References 

  1. Kessinger A, Schmit-Pokorny K, Smith D, Armitage J. Cryopreservation and infusion of autologous peripheral blood stem cells. Bone Marrow Transplant. 1990;5(Suppl 1):25–27
  2. Williams SF, Bitran JD, Richards JM, et al. Peripheral blood-derived stem cell collections for use in autologous transplantation after high dose chemotherapy: an alternative approach. Bone Marrow Transplant. 1990;5:129–133
  3. Jacobs P, Wood L, Horak S. Collection and cryopreservation of human stem and progenitor cells for bone marrow transplantation. J Clin Apher. 1991;6:54–58
  4. Harada M, Taniguchi S, Teshima T, et al. Cryopreservation, cytokine mobilization, and autotransplantation of peripheral blood stem cells. Prog Clin Biol Res. 1992;377:297–308
  5. Zambelli A, Poggi G, Prada GD, et al. Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res. 1998;18:4705–4708
  6. Zenhausern R, Tobler A, Leoncini L, Hess OM, Ferrari P. Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure. Ann Hematol. 2000;79:523–526
  7. Keung YK, Lau S, Elkayam U, Chen SC, Douer D. Cardiac arrhythmia after infusion of cryopreserved stem cells. Bone Marrow Transplant. 1994;14:363–367
  8. Alessandrino P, Bernasconi P, Caldera D, et al. Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. Bone Marrow Transplant. 1999;23:533–537
  9. de Vries EG, Vellenga E, Kluin-Nelemans JC, Mulder NH. The happy destiny of frozen haematopoietic stem cells: from immature stem cells to mature applications. Eur J Cancer. 2004;40:1987–1992
  10. Handelsman H. Autologous peripheral stem-cell transplantation. Health Technol Assess (Rockv). 1995;1–16
  11. Shpall EJ, Champlin R, Glaspy JA. Effect of CD34+ peripheral blood progenitor cell dose on hematopoietic recovery. Biol Blood Marrow Transplant. 1998;4:84–92
  12. Saba N, Abraham R, Keating A. Overview of autologous stem cell transplantation. Crit Rev Oncol Hematol. 2000;36:27–48
  13. Stockschlader M, Kruger W, Dieck At, et al. Use of cryopreserved bone marrow in unrelated allogeneic transplantation. Bone Marrow Transplant. 1996;17:197–199
  14. Stockschlader M, Hassan HT, Krog C, et al. Long-term follow-up of leukaemia patients after related cryopreserved allogeneic bone marrow transplantation. Br J Haematol. 1997;96:382–386
  15. Harris DT, Schumacher MJ, Rychlik S, et al. Collection, separation and cryopreservation of umbilical cord blood for use in transplantation. Bone Marrow Transplant. 1994;13:135–143
  16. Frey NV, Lazarus HM, Goldstein SC. Has allogeneic stem cell cryopreservation been given the “cold shoulder”? (An analysis of the pros and cons of using frozen versus fresh stem cell products in allogeneic stem cell transplantation). Bone Marrow Transplant. 2006;38:399–405
  17. Galmes A, Besalduch J, Bargay J, et al. Cryopreservation of hematopoietic progenitor cells with 5-percent dimethyl sulfoxide at −80 degrees C without rate-controlled freezing. Transfusion. 1996;36:794–797
  18. Galmes A, Besalduch J, Bargay J, et al. A simplified method for cryopreservation of hematopoietic stem cells with −80 degrees C mechanical freezer with dimethyl sulfoxide as the sole cryoprotectant. Leuk Lymphoma. 1995;17:181–184
  19. Galmes A, Besalduch J, Bargay J, et al. Long-term storage at −80 degrees C of hematopoietic progenitor cells with 5-percent dimethyl sulfoxide as the sole cryoprotectant. Transfusion. 1999;39:70–73
  20. Itoh T, Minegishi M, Fushimi J, et al. A simple controlled-rate freezing method without a rate-controlled programmed freezer provides optimal conditions for both large-scale and small-scale cryopreservation of umbilical cord blood cells. Transfusion. 2003;43:1303–1308
  21. Pond GR, Lipton JH, Messner HA. Long-term survival after blood and marrow transplantation: comparison with an age- and gender-matched normative population. Biol Blood Marrow Transplant. 2006;12:422–429
  22. Gupta V, Daly A, Lipton JH, et al. Nonmyeloablative stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia in patients 60 years or older. Biol Blood Marrow Transplant. 2005;11:764–772
  23. Kiss TL, Panzarella T, Messner HA, et al. Busulfan and cyclophosphamide as a preparative regimen for allogeneic blood and marrow transplantation in patients with non-Hodgkin’s lymphoma. Bone Marrow Transplant. 2003;31:73–78
  24. Messner HA. Long-term outcome of allogeneic transplants in acute myeloid leukemia. Leukemia. 2002;16:751–752
  25. Fietz T, Reufi B, Mucke C, Thiel E, Knauf WU. Flow cytometric CD34+ determination in stem cell transplantation: before or after cryopreservation of grafts?. J Hematother Stem Cell Res. 2002;11:429–435
  26. Abrahamsen JF, Wentzel-Larsen T, Bruserud O. Autologous transplantation: the viable transplanted CD34+ cell dose measured post-thaw does not predict engraftment kinetics better than the total CD34+ cell dose measured pre-freeze in patients that receive more than 2×10(6) CD34+ cells/kg. Cytotherapy. 2004;6:356–362
  27. Korbling M, Huh YO, Durett A, et al. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood. 1995;86:2842–2848
  28. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man (A long-term clinicopathologic study of 20 Seattle patients). Am J Med. 1980;69:204–217
  29. Parimon T, Au DH, Martin PJ, Chien JW. A risk score for mortality after allogeneic hematopoietic cell transplantation. Ann Intern Med. 2006;144:407–414
  30. Webb IJ, Coral FS, Andersen JW, et al. Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering. Transfusion. 1996;36:782–788
  31. Schwella N, Zimmermann R, Heuft HG, et al. Microbiologic contamination of peripheral blood stem cell autografts. Vox Sang. 1994;67:32–35
  32. Cashen AF, Nervi B, DiPersio J. AMD3100: CXCR4 antagonist and rapid stem cell-mobilizing agent. Future Oncol. 2007;3:19–27
  33. Fruehauf S, Seeger T, Topaly J. Innovative strategies for PBPC mobilization. Cytotherapy. 2005;7:438–446
  34. Eckardt JR, Roodman GD, Boldt DH, et al. Comparison of engraftment and acute GVHD in patients undergoing cryopreserved or fresh allogeneic BMT. Bone Marrow Transplant. 1993;11:125–131
  35. Auletta JJ, Lazarus HM. Immune restoration following hematopoietic stem cell transplantation: an evolving target. Bone Marrow Transplant. 2005;35:835–857
  36. Xu Y, Kashiwakura I, Takahashi TA. High sensitivity of megakaryocytic progenitor cells contained in placental/umbilical cord blood to the stresses dugin cryopreservation. Bone Marrow Transplant. 2004;34:537–543

PII: S1083-8791(07)00348-5

doi: 10.1016/j.bbmt.2007.07.003

Biology of Blood and Marrow Transplantation
Volume 13, Issue 10 , Pages 1233-1243 , October 2007

Article Tools

* Image Usage & Resolution